603 related articles for article (PubMed ID: 26481318)
1. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.
Gijselinck I; Van Mossevelde S; van der Zee J; Sieben A; Engelborghs S; De Bleecker J; Ivanoiu A; Deryck O; Edbauer D; Zhang M; Heeman B; Bäumer V; Van den Broeck M; Mattheijssens M; Peeters K; Rogaeva E; De Jonghe P; Cras P; Martin JJ; de Deyn PP; Cruts M; Van Broeckhoven C
Mol Psychiatry; 2016 Aug; 21(8):1112-24. PubMed ID: 26481318
[TBL] [Abstract][Full Text] [Related]
2. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients.
Xi Z; Zhang M; Bruni AC; Maletta RG; Colao R; Fratta P; Polke JM; Sweeney MG; Mudanohwo E; Nacmias B; Sorbi S; Tartaglia MC; Rainero I; Rubino E; Pinessi L; Galimberti D; Surace EI; McGoldrick P; McKeever P; Moreno D; Sato C; Liang Y; Keith J; Zinman L; Robertson J; Rogaeva E
Acta Neuropathol; 2015 May; 129(5):715-27. PubMed ID: 25716178
[TBL] [Abstract][Full Text] [Related]
3. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients.
Xi Z; Rainero I; Rubino E; Pinessi L; Bruni AC; Maletta RG; Nacmias B; Sorbi S; Galimberti D; Surace EI; Zheng Y; Moreno D; Sato C; Liang Y; Zhou Y; Robertson J; Zinman L; Tartaglia MC; St George-Hyslop P; Rogaeva E
Hum Mol Genet; 2014 Nov; 23(21):5630-7. PubMed ID: 24908669
[TBL] [Abstract][Full Text] [Related]
5. The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype.
Cooper-Knock J; Shaw PJ; Kirby J
Acta Neuropathol; 2014 Mar; 127(3):333-45. PubMed ID: 24493408
[TBL] [Abstract][Full Text] [Related]
6. Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum.
Cruts M; Gijselinck I; Van Langenhove T; van der Zee J; Van Broeckhoven C
Trends Neurosci; 2013 Aug; 36(8):450-9. PubMed ID: 23746459
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion.
Xi Z; Zinman L; Moreno D; Schymick J; Liang Y; Sato C; Zheng Y; Ghani M; Dib S; Keith J; Robertson J; Rogaeva E
Am J Hum Genet; 2013 Jun; 92(6):981-9. PubMed ID: 23731538
[TBL] [Abstract][Full Text] [Related]
8. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
[TBL] [Abstract][Full Text] [Related]
9. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients.
Belzil VV; Bauer PO; Gendron TF; Murray ME; Dickson D; Petrucelli L
Brain Res; 2014 Oct; 1584():15-21. PubMed ID: 24530272
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and genetic characterization of two dizygotic twins with C9orf72 expansion.
Conforti FL; Tortelli R; Morello G; Capozzo R; Barulli MR; Cavallaro S; Logroscino G
Neurobiol Aging; 2018 Sep; 69():293.e1-293.e8. PubMed ID: 29866399
[TBL] [Abstract][Full Text] [Related]
11. C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
Xiao S; MacNair L; McLean J; McGoldrick P; McKeever P; Soleimani S; Keith J; Zinman L; Rogaeva E; Robertson J
Brain Res; 2016 Sep; 1647():43-49. PubMed ID: 27134035
[TBL] [Abstract][Full Text] [Related]
12. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
[TBL] [Abstract][Full Text] [Related]
13. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.
Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M
Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838
[TBL] [Abstract][Full Text] [Related]
14. The association between repeat number in C9orf72 and phenotypic variability in Turkish patients with frontotemporal lobar degeneration.
Erzurumluoglu E; Cilingir O; Ozbabalik Adapinar BD; Bilgic B; Kocagil S; Ozen H; Durak Aras B; Yenilmez C; Artan S
Neurobiol Aging; 2019 Apr; 76():216.e1-216.e7. PubMed ID: 30685122
[TBL] [Abstract][Full Text] [Related]
15. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.
Liu EY; Russ J; Wu K; Neal D; Suh E; McNally AG; Irwin DJ; Van Deerlin VM; Lee EB
Acta Neuropathol; 2014 Oct; 128(4):525-41. PubMed ID: 24806409
[TBL] [Abstract][Full Text] [Related]
16. Jump from pre-mutation to pathologic expansion in C9orf72.
Xi Z; van Blitterswijk M; Zhang M; McGoldrick P; McLean JR; Yunusova Y; Knock E; Moreno D; Sato C; McKeever PM; Schneider R; Keith J; Petrescu N; Fraser P; Tartaglia MC; Baker MC; Graff-Radford NR; Boylan KB; Dickson DW; Mackenzie IR; Rademakers R; Robertson J; Zinman L; Rogaeva E
Am J Hum Genet; 2015 Jun; 96(6):962-70. PubMed ID: 26004200
[TBL] [Abstract][Full Text] [Related]
17. Drosha inclusions are new components of dipeptide-repeat protein aggregates in FTLD-TDP and ALS C9orf72 expansion cases.
Porta S; Kwong LK; Trojanowski JQ; Lee VM
J Neuropathol Exp Neurol; 2015 Apr; 74(4):380-7. PubMed ID: 25756586
[TBL] [Abstract][Full Text] [Related]
18. Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.
Stepto A; Gallo JM; Shaw CE; Hirth F
Acta Neuropathol; 2014 Mar; 127(3):377-89. PubMed ID: 24366528
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier.
Russ J; Liu EY; Wu K; Neal D; Suh E; Irwin DJ; McMillan CT; Harms MB; Cairns NJ; Wood EM; Xie SX; Elman L; McCluskey L; Grossman M; Van Deerlin VM; Lee EB
Acta Neuropathol; 2015 Jan; 129(1):39-52. PubMed ID: 25388784
[TBL] [Abstract][Full Text] [Related]
20. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.
Gallagher MD; Suh E; Grossman M; Elman L; McCluskey L; Van Swieten JC; Al-Sarraj S; Neumann M; Gelpi E; Ghetti B; Rohrer JD; Halliday G; Van Broeckhoven C; Seilhean D; Shaw PJ; Frosch MP; Alafuzoff I; Antonell A; Bogdanovic N; Brooks W; Cairns NJ; Cooper-Knock J; Cotman C; Cras P; Cruts M; De Deyn PP; DeCarli C; Dobson-Stone C; Engelborghs S; Fox N; Galasko D; Gearing M; Gijselinck I; Grafman J; Hartikainen P; Hatanpaa KJ; Highley JR; Hodges J; Hulette C; Ince PG; Jin LW; Kirby J; Kofler J; Kril J; Kwok JB; Levey A; Lieberman A; Llado A; Martin JJ; Masliah E; McDermott CJ; McKee A; McLean C; Mead S; Miller CA; Miller J; Munoz DG; Murrell J; Paulson H; Piguet O; Rossor M; Sanchez-Valle R; Sano M; Schneider J; Silbert LC; Spina S; van der Zee J; Van Langenhove T; Warren J; Wharton SB; White CL; Woltjer RL; Trojanowski JQ; Lee VM; Van Deerlin V; Chen-Plotkin AS
Acta Neuropathol; 2014 Mar; 127(3):407-18. PubMed ID: 24442578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
